Superworth

Boston Scientific price to free cash flow BSX

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026
18.3×
10-year median
56.0×
Against its 10-year history
1st
percentile: 0 is its lowest day, 100 its highest
10-year range
17.0× to 404×
Peer median
20.7×

Boston Scientific's price to free cash flow is 18.3× as of Oct 23, 2026.

That is below its ten-year median of 56.0×, lower than on 99% of days in the last ten years.

Over that time it ranged from 17.0× in Oct 2026 to 404× in Jun 2019.

The median for 7 medical device stocks of a similar size is 20.7×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far18.3×17.0×37.9×
202537.2×35.9×72.5×
202462.0×50.2×70.4×
202349.9×44.5×125×
2022119×37.1×120×
202137.4×33.1×54.6×
202045.8×27.7×81.4×
201980.6×54.2×404×
201854.9×32.7×82.7×
201755.5×55.5×129×
201654.4×30.6×83.7×
201552.8×20.9×58.2×
201420.8×16.7×23.8×
201316.9×8.2×16.9×
20127.7×6.9×12.9×
20119.6×9.2×217×

Against its peers

Companies in Medical - Devices nearest Boston Scientific's size, closest first, today.

CompanyPrice to free cash flow
BSXBoston Scientific18.3×
EWEdwards Lifesciences35.8×
SYKStryker25.1×
MDTMedtronic19.9×
GEHCGE HealthCare Technologies20.4×
DXCMDexCom20.9×
ABTAbbott Laboratoriesn/m
ZBHZimmer Biomet12.3×
Peer median20.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Boston Scientific

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.